A groundbreaking study from the University of Colorado Boulder has revealed that CBD-dominant cannabis products may be more effective at reducing anxiety than THC-dominant alternatives, without the potential side effects associated with THC.The research, published in the journal Cannabis and Cannabinoid Research, involved 300 participants and is the first randomized trial to examine how commercially available cannabis impacts anxiety symptoms.Lead researcher Cinnamon Bidwell noted, “CBD was associated with tension and anxiety relief with limited harm.” The study found that participants using CBD-dominant products experienced greater reductions in anxiety compared to those using THC-dominant or balanced products.While more research is needed to confirm long-term effects, this study provides promising evidence for the potential of CBD in anxiety treatment. As anxiety disorders affect one in five U.S. adults, these findings could have significant implications for mental health care.